Chest Infections
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Panel to outline growing impact of climate change in critical care
Stephanie Maximous, MD, MS, will chair a Sunday morning session on climate change’s growing encroachments in critical illness and acute conditions such as heart attacks, strokes, and asthma exacerbations.
-
Session to review latest science, recommendations for vaccines against respiratory infections
Charles Dela Cruz, MD, PhD, will chair a Sunday afternoon session on current practice recommendations for COVID-19, influenza, RSV, and pneumococcal vaccines.
-
Azelastine nasal spray shows promise in preventing SARS-CoV-2 infections
Researcher Robert Bals, MD, PhD, said this is a starting point, a signal of efficacy that warrants confirmation in larger, multicentric, phase 3 trials.
-
Session to outline strategies for emerging pathogen preparedness
Kevin Swiatek, DO, FCCP, will chair a session addressing obstacles to and opportunities for a comprehensive response to emerging pathogens in the United States.
-
Moderate to severe OSA increases risk of severe COVID-19
According to critical care specialist Lina Miyakawa, MD, FCCP, the findings are a reminder that OSA “is not just a sleep disorder but a systemic condition with meaningful public health implications.”
-
Airway crossroads: The overlap of bronchiectasis and obstructive lung disease
Bronchiectasis frequently coexists with asthma or COPD, forming an overlap phenotype that’s increasingly recognized but often overlooked.
-
Oseltamivir beats supportive care for patients hospitalized with seasonal influenza
Investigator Anthony Bai, MD, MSc, and infectious disease expert Christina Thornton, MD, PhD, discuss a large analysis that showed an in-hospital mortality rate of 3.5% for oseltamivir vs 4.9% for supportive care.
-
EHR data confirm effectiveness of RSV vaccine in adults aged 60 and older
Pauline Terebuh, MD, MPH, said the results aligned with previous trials; however, Shaun J. Grannis, MD, said more data are needed to determine the durability of the protection.
-
Medical preparedness and critical care for the 2026 FIFA World Cup
In 2026, the FIFA World Cup will land in North America, whose health care infrastructure must be equipped to handle infectious disease threats, health care surges, mass casualty events, routine injuries, and chronic conditions.
-
Bridging Specialties program tackles NTM pulmonary disease and bronchiectasis
CHEST launched Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis as a way for PCPs and pulmonologists to collaborate and provide earlier and accurate diagnoses.
-
Hope on the horizon for bronchiectasis
The combination of personalized therapies, novel and repurposed medications, and a multidisciplinary approach is transforming bronchiectasis from a condition that once had few treatment options into one that offers hope for improved management and even disease stabilization.
